Previous 10 | Next 10 |
home / stock / aqs:cc / aqs:cc news
VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on Tuesday, July 19, 2022, he acquired ownership (the “ Acquisition ”) of 100,000 common shares (“ Common S...
IIROC Trading Resumption - AQS Canada NewsWire VANCOUVER, BC , July 13, 2022 /CNW/ - Trading resumes in: Company: Aequus Pharmaceuticals Inc. TSX-Venture Symbol: AQS All Issues: Yes Resumption (ET): 9:30 AM , 07/14 IIROC ca...
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news release dated July 6, 2022, we will resume trading on the TSX Venture exchange tomorrow, July 14, 2022. Doug Janzen noted that ...
VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of an exclusive distribution agreement with SCOPE Ophthalmics. (“SCOPE ...
Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a...
IIROC Trading Halt - AQS Canada NewsWire VANCOUVER, BC , May 10, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Aequus Pharmaceuticals Inc. TSX-Venture Symbol: AQS All Issues: Yes Reason: Cease Trade Order Halt Time ...
VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that further to its news release on May 2, 2022, the filing of its audited annual fina...
VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that the filing of its audited annual financial statements for the fiscal year ended D...
IIROC Trading Halt - AQS.DB Canada NewsWire VANCOUVER, BC , May 2, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Aequus Pharmaceuticals Inc. TSX-Venture Symbol: AQS.DB All Issues: No Reason: Pending Delisting Halt T...
VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that it has entered into an agreement with Mr. Doug Janzen, Chairman and Chief Executi...
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc. Company Name:
AQS:CC Stock Symbol:
TSXVC Market:
Aequus Pharmaceuticals Inc. Website:
A look at the top 10 most actives in Canada Fission Uranium Corp. (FCU) rose 2.4% to $1.3 on volume of 2,644,341 shares Toronto-Dominion Bank (The) (TD) fell 0.7% to $75.62 on volume of 1,933,419 shares HPQ Silicon Inc. (HPQ) rose 15.1% to $0.42 on volume of 1,173,583 shares WonderFi Te...
(TheNewswire) VANCOUVER, BC. July 3 rd – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, announces...
(TheNewswire) VANCOUVER – TheNewswire - May 22, 2024 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licen...